Correlation between cytoreduction outcome and staging of ovarian cancer with preoperative blood cell count
10.3760/cma.j.issn.1008-1372.2017.01.023
- VernacularTitle:卵巢癌减瘤术结局及病理分期与术前血细胞计数的关系
- Author:
Feng CHENG
;
Jianqing ZHU
- Keywords:
Ovarian neoplasms/SU/PA/BL;
Neoplasm staging;
Blood cell count
- From:
Journal of Chinese Physician
2017;19(1):83-85
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the relationship between cytoreduction outcome and staging of ovarian cancer with preoperative blood cell count.Methods The data of 148 ovarian cancer patients from January 2007 to June 2012 were analyzed retrospectively.Clinicopathological and blood cell count data were collected,and benign ovarian tumor group (n =96) as controls.Results Compared to the control group,there were significant differences in the number of white blood cells,neutrophils,lymphocytes,monocytes,platelets,neutrophil to lymphocyte ratio,and platelets to lymphocyte ratio in patients with ovarian cancer (P ＜ 0.05).The same results were also observed in advanced groups and early groups.While between optimal cytoreduction and suboptimal cytoreduction,there were significant differences in platelets,monocytes,neutrophil to lymphocyte ratio,and platelets to lymphocyte ratio (P ＜ 0.05).Conclusions The cytoreduction outcome and pathological staging of ovarian cancer are closely related to the preoperative blood cell count.Blood cell count is important for the identification of benign and malignant ovarian tumors,cytoreduction outcome and the prediction of pathological staging,and may be of significance to the monitoring and prognosis of the disease.
